Found 130 matching trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as capecitabine and vinorelbine...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects PHASE3 This study is a randomized controlled, open-label, multicenter phase III cl...
Show More Learn More & Join Trial
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients PHASE1 To determine the safety of administering anakinra plus the physician's chem...
Show More Location
Baylor University Medical Center
Learn More & Join Trial
Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer PHASE2 This is a Phase II, open-label, single-arm study evaluating the efficacy an...
Show More Location
breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer PHASE3 The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab...
Show More Location
Southern Cancer Center
Learn More & Join Trial
Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer PHASE2 This is an open-label, non-randomised, phase II study to evaluate the effic...
Show More Location
Multiple Locations
Learn More & Join Trial
Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer PHASE3 Primary objective of the study in patients without a sufficient sonographic...
Show More Location
Multiple Locations
Learn More & Join Trial
SMMART Adaptive Clinical Treatment (ACT) Trial EARLY_PHASE1 SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer PHASE2 This is a therapeutic exploratory Phase 2 study evaluating AEZS-108 compare...
Show More Location
University of Miami
Learn More & Join Trial
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer PHASE2 This phase II trial is studying how well giving hormone therapy together wi...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial